All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia.
Degos
L
L
Institut Universitaire D'Hematologie, Hopital Saint-Louis, Paris, France.
D002352:Carrier Proteins / Q000235:genetics; D002454:Cell Differentiation / Q000187:drug effects; D004351:Drug Resistance; D015321:Gene Rearrangement; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D007964:Leukocytosis / Q000139:chemically induced; D018168:Receptors, Retinoic Acid; D014212:Tretinoin / Q000494:pharmacology / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured
D002352:Carrier Proteins; D018168:Receptors, Retinoic Acid; D014212:Tretinoin